InvestSMART

Mayne Pharma Group Limited (ASX:MYX)

ALERT: Price-sensitive ASX Announcement for MYX
Current share price for MYX : $2.340 -0.86 (-26.88%)+
Announcement
Release
10 Dec 2025 9:43AM
Price at Release
$3.200
Full Release
download
Summary
Mayne Pharma Group Limited announced that it received a notice from Cosette Pharmaceuticals claiming termination of the Scheme Implementation Deed due to unsatisfied FIRB conditions. Despite attempts to consult, no agreement was reached to advance the Scheme. Mayne Pharma rejects Cosette's notice as invalid, asserting that Cosette's failure to meet its obligations contributed to the issue. Mayne Pharma reserves its rights concerning Cosette's non-performance under the agreement.
Key Points
  • Mayne Pharma received a purported notice to terminate the Scheme Implementation Deed from Cosette.
  • Cosette notified Mayne Pharma of a failure to satisfy the FIRB condition precedent.
  • Mayne Pharma has been unable to reach an agreement with Cosette to proceed with the Scheme.
  • Cosette issued a termination notice citing specific clauses of the Scheme Implementation Deed.
  • Mayne Pharma rejects the termination notice as invalid due to Cosette's failure to fulfill its obligations.
  • Mayne Pharma reserves its rights regarding Cosette's failure to perform under the deed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.